87 related articles for article (PubMed ID: 6305429)
1. Nootropics: status and prospects.
Itil TM
Biol Psychiatry; 1983 May; 18(5):521-3. PubMed ID: 6305429
[No Abstract] [Full Text] [Related]
2. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
Prusiński A; Kotwica S; Niewodniczy A; Split W
Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
[No Abstract] [Full Text] [Related]
3. [Further observations on the use of Suloctidil (Sulocton) in the treatment of migraine].
Prusiński A; Durko A; Głuszcz-Zielińska A; Szymańska R
Wiad Lek; 1984 Dec; 37(23):1857-9. PubMed ID: 6099634
[No Abstract] [Full Text] [Related]
4. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
[No Abstract] [Full Text] [Related]
5. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
[No Abstract] [Full Text] [Related]
6. Intermittent claudication: Suloctidil v.s. placebo treatment.
Holm J; Lindblad L; Scherstén T; Suurkula M
Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
[No Abstract] [Full Text] [Related]
7. [Suloctidil in the treatment of focal cerebral ischemia].
Bartko D; Zúzi M; Brezná M; Trávniková M; Porubec V
Cesk Neurol Neurochir; 1984 Mar; 47(2):103-8. PubMed ID: 6323038
[No Abstract] [Full Text] [Related]
8. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
[No Abstract] [Full Text] [Related]
9. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
10. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
11. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
Armani U; Piana A
Arch Maragliano Patol Clin; 1979; 35(2):57-62. PubMed ID: 233645
[No Abstract] [Full Text] [Related]
12. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic-pharmacological effect on cerebral circulation evaluated by means of computerized CW Doppler signal spectrum analysis--first experiments on the action of Suloctidil.
De Fabritiis A; Guastarobba A; Scondotto G; Borgatti E
Monogr Neural Sci; 1984; 11():243-50. PubMed ID: 6330541
[No Abstract] [Full Text] [Related]
14. [A new preparation for peripheral arterial occlusive diseases].
Knüchel F
Med Welt; 1982 Jan; 33(1):90. PubMed ID: 6276645
[No Abstract] [Full Text] [Related]
15. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
Petronio G; Scali G; Casa B; Nonis E
Clin Ter; 1980 Aug; 94(4):427-44. PubMed ID: 6257445
[No Abstract] [Full Text] [Related]
16. Suloctidil therapy in migraine: an open pilot study.
Prusiński A; Durko A; Głuszcz-Zielińska A; Szymańska R
Curr Med Res Opin; 1983; 8(9):631-3. PubMed ID: 6321107
[TBL] [Abstract][Full Text] [Related]
17. Effect of suloctidil on platelet function in patients with shortened platelet survival time.
Turpie AG; Gent M; deBoer AC; Giroux M; Kinch D; Butt R; Gunstensen J; Saerens E; Genton E
Thromb Res; 1984 Aug; 35(4):397-406. PubMed ID: 6091290
[TBL] [Abstract][Full Text] [Related]
18. Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial.
Chieffo C; Postiglione A; Tritto C; Mancini M
Curr Med Res Opin; 1984; 9(3):147-52. PubMed ID: 6094103
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of sulocton action in patients with atherosclerotic brain ischemia].
Karwowski B; Jura E; Krasicka J; Kruszewska J; Laskowska-Studniarska W; Szymchel J; Nielubowiczowa H
Neurol Neurochir Pol; 1982; 16(4):237-43. PubMed ID: 6292759
[TBL] [Abstract][Full Text] [Related]
20. Suloctidil-induced hepatotoxicity.
Chung MW; Komorowski RA; Varma RR
Gastroenterology; 1988 Aug; 95(2):490-1. PubMed ID: 2839389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
